Keck School Faculty

David Geller, MD, PhD
David Geller, MD, PhD
Professor of Clinical Pediatrics
Pediatrics
CHLA 4650 W. Sunset Blvd. Off Campus Los Angeles

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients J Cyst Fibros. 2016 Jul; 15(4):495-502. . View in PubMed

Inhalation of tobramycin using simulated cystic fibrosis patient profiles Pediatr Pulmonol. 2016 11; 51(11):1159-1167. . View in PubMed

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients J Cyst Fibros. 2016 07; 15(4):495-502. . View in PubMed

Tiotropium Respimat in cystic fibrosis: Phase 3 and Pooled phase 2/3 randomized trials J Cyst Fibros. 2015 Sep; 14(5):608-14. . View in PubMed

A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients J Cyst Fibros. 2015 Jul; 14(4):507-14. . View in PubMed

Pooled analysis of tiotropium Respimat(®) pharmacokinetics in cystic fibrosis Pulm Pharmacol Ther. 2014 Dec; 29(2):217-23. . View in PubMed

Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection Pediatr Pulmonol. 2014 Jul; 49(7):650-8. . View in PubMed

Tobramycin inhalation powder in cystic fibrosis patients: response by age group Respir Care. 2014 Mar; 59(3):388-98. . View in PubMed

Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results PLoS One. 2014; 9(9):e106195. . View in PubMed

Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis J Cyst Fibros. 2013 Jul; 12(4):367-76. . View in PubMed

Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation Chest. 2012 Sep; 142(3):718-724. . View in PubMed

Improvements in quality of life after surgery for benign hepatic tumors: Results from a dual center analysis Surgery. 2012 Aug; 152(2):193-201. . View in PubMed

Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study Am J Respir Crit Care Med. 2012 Mar 15; 185(6):645-52. . View in PubMed

A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis Pediatr Pulmonol. 2012 Mar; 47(3):252-63. . View in PubMed

Fosfomycin/tobramycin for inhalation in patients with cystic fibrosis with pseudomonas airway infection Am J Respir Crit Care Med. 2012 Jan 15; 185(2):171-8. . View in PubMed

Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases? J Surg Oncol. 2012 Jan; 105(1):55-9.. View in PubMed

Therapeutic approaches to chronic cystic fibrosis respiratory infections with available, emerging aerosolized antibiotics Respir Med. 2011 Dec; 105 Suppl 2:S2-8. . View in PubMed

Pharmacokinetics and safety of MP-376 (levofloxacin inhalation solution) in cystic fibrosis subjects Antimicrob Agents Chemother. 2011 Jun; 55(6):2636-40. . View in PubMed

Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas aeruginosa Am J Respir Crit Care Med. 2011 Jun 01; 183(11):1510-6. . View in PubMed

Tobramycin inhalation powder for Paeruginosa infection in cystic fibrosis: the EVOLVE trial. Pediatr Pulmonol. 2011 Mar; 46(3):230-8. . View in PubMed

Tobramycin administered by the TOBI(®) Podhaler(®) for persons with cystic fibrosis: a review Med Devices (Auckl). 2011; 4:179-88. . View in PubMed

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial J Cyst Fibros. 2011 Jan; 10(1):54-61. . View in PubMed

Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety Pediatr Pulmonol. 2007 Apr; 42(4):307-13. . View in PubMed

A multi-method assessment of treatment adherence for children with cystic fibrosis J Cyst Fibros. 2006 Aug; 5(3):177-85. . View in PubMed

Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable asthma and COPD: focus on budesonide Respir Med. 2005 Jul; 99(7):836-49. . View in PubMed

Bolus inhalation of rhDNase with the AERx system in subjects with cystic fibrosis J Aerosol Med. 2003; 16(2):175-82. . View in PubMed

Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system Chest. 2003 Jan; 123(1):28-36. . View in PubMed

Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis Chest. 2002 Jul; 122(1):219-26. . View in PubMed

Powered by SC CTSI
Go to Top